NCT04260373View on ClinicalTrials.gov

Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 19, 2020

Primary Completion Date

April 3, 2020

Study Completion Date

April 3, 2020

Conditions

Healthy Adult Male Volunteers

Interventions

DRUG

[14C]SHR4640

Patients will receive single dose of orally \[14C\]SHR4640 on Day 1.

Trial Locations (1)

215006

First Affiliated Hospital, Soochow University, Suzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04260373 - Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers. | Biotech Hunter | Biotech Hunter